Purdue Pharma

URI: https://gptkb.org/entity/Purdue_Pharma

GPTKB entity

Statements (69)

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology
gptkbp:CEO	gptkb:Craig_Landau
gptkbp:containsSettlement	$8 billion (2020)
gptkbp:country	gptkb:United_States
gptkbp:filedForBankruptcy	2019
gptkbp:focus	pain management medications
gptkbp:foundedBy	gptkb:George_Frederick_Bingham gptkb:John_Purdue_Gray
gptkbp:foundedYear	1892
gptkbp:headquartersLocation	gptkb:Stamford,_Connecticut,_United_States
https://www.w3.org/2000/01/rdf-schema#label	Purdue Pharma
gptkbp:industry	pharmaceuticals
gptkbp:legalIssue	opioid crisis lawsuits
gptkbp:marketedDrug	gptkb:Ryzodeg gptkb:Betadine gptkb:Buprenorphine gptkb:Hydromorphone gptkb:Oxycodone gptkb:Senna gptkb:Naloxone gptkb:Intermezzo gptkb:Betasept gptkb:Bisacodyl gptkb:Butrans gptkb:Colace gptkb:DHC_Capsules gptkb:DHC_Continus gptkb:DHC_ER gptkb:DHC_IR gptkb:DHC_Injection gptkb:DHC_Liquid gptkb:DHC_Oral_Capsules gptkb:DHC_Oral_Drops gptkb:DHC_Oral_Granules gptkb:DHC_Oral_Liquid gptkb:DHC_Oral_Powder gptkb:DHC_Oral_Sachets gptkb:DHC_Oral_Solution gptkb:DHC_Oral_Suspension gptkb:DHC_Oral_Syrup gptkb:DHC_Oral_Tablets gptkb:DHC_Plus gptkb:DHC_Solution gptkb:DHC_Suppositories gptkb:DHC_Syrup gptkb:DHC_Tablets gptkb:DHC_Tabs gptkb:Dilaudid gptkb:Hysingla_ER gptkb:MSIR gptkb:OxyFast gptkb:OxyIR gptkb:OxyNeo gptkb:OxyNorm gptkb:Palladone gptkb:Rhythmol gptkb:Ryzolt gptkb:Senokot gptkb:Sevoflurane gptkb:Targiniq_ER Laxatives
gptkbp:notableProduct	gptkb:OxyContin gptkb:MS_Contin
gptkbp:ownedBy	gptkb:Sackler_family
gptkbp:parentCompany	gptkb:Mundipharma
gptkbp:type	gptkb:public_company
gptkbp:website	https://www.purduepharma.com/
gptkbp:bfsParent	gptkb:Susan_Sackler
gptkbp:bfsLayer	5